Medication Safety
16 articles on Medication Safety, written by Shotlee and medically reviewed for clinical accuracy.
Alli Weight Loss Pill: FDA Flags Serious Kidney Risks
The Food and Drug Administration (FDA) has issued a new warning regarding potential serious kidney complications associated with Alli, the sole over-the-counter weight loss medication available in the United States. The drug's label has been updated to reflect these risks, urging caution for consumers.
8 min read
Alli's Kidney Risk: FDA Updates Label for Over-the-Counter Weight Loss Pill
The FDA has issued a critical update to the drug facts label for Alli, the only over-the-counter weight loss medication available in the U.S. The changes highlight rare but potentially severe kidney-related side effects, prompting new warnings for consumers.
7 min read
Retatrutide Phase 3 Results: 28% Weight Loss and the Triple Agonist Promise
Eli Lilly has released pivotal Phase 3 trial data for retatrutide, a triple agonist showing up to 28% body weight reduction and significant improvements in diabetes and sleep apnea.
7 min read
Ozempic Weight Loss: Why Your Body Needs One More Key Step
Ozempic is a household name, but experts warn it isn't a magic bullet. Dr. Shilpa Verma discusses the essential lifestyle component required for sustainable weight loss.
6 min read
Beyond the Needle: Why Wegovy Alone Can't Cure New Zealand's Obesity Crisis
As New Zealand considers public funding for Wegovy, experts warn that medication alone cannot solve the obesity epidemic driven by complex environmental and social factors.
8 min read
Illicit Weight Loss Drug Ring Dismantled: 12,000 Doses Seized
A major bust at a country estate near Northampton has led to the seizure of 12,000 doses of illicit weight loss medications, including potent peptide drugs. Two men have been arrested as the Medicines and Healthcare products Regulatory Agency (MHRA) cracks down on dangerous counterfeit and unlicensed medicines.
6 min read
GLP-1 Drugs and Vision Loss: Understanding NAION Lawsuits
Recent lawsuits are raising serious questions about the potential for GLP-1 medications, widely used for diabetes and weight loss, to cause a rare but devastating eye condition known as NAION, leading to permanent vision loss. This article delves into the allegations, scientific evidence, and ongoing legal proceedings.
6 min read
FDA Warning: How to Spot Fake Tirzepatide and Stay Safe on Weight Loss
The FDA has issued a critical warning regarding counterfeit tirzepatide products. Discover the risks of fake GLP-1 medications and how to verify legitimate sources for your weight loss journey.
6 min read
GLP-1 Safety: FDA Action, TrumpRx Access & Weight Loss Drug Risks
Explore the critical safety differences between compounded GLP-1 medications and FDA-approved treatments. Understand the role of new access programs in combating unsafe alternatives.
9 min read
Greg Davies Ozempic Weight Loss: Key Lessons for GLP-1 Users
Comedian Greg Davies reveals the physical and psychological effects of stopping Ozempic after significant weight loss, offering insights for patients on peptide therapy.
6 min read
GLP-1 Agonists for Psoriasis: New Hope for Weight & Inflammation
A comprehensive guide to the National Psoriasis Foundation's findings on GLP-1 receptor agonists as adjunct therapy for psoriasis, including trial data and monitoring strategies.
9 min read
FDA's GLP-1 Compounding Crackdown: What Patients Need to Know
The U.S. Food and Drug Administration (FDA) has announced a significant proposal to restrict the compounding of popular GLP-1 medications, including semaglutide and tirzepatide. This move aims to enhance patient safety and uphold the integrity of approved drug products. Here's a comprehensive look at what this means for individuals managing weight and diabetes.
7 min read
Semaglutide NAION Risk: New Study Findings for Weight Loss Patients
A recent analysis published in JAMA Ophthalmology reveals a significant increase in NAION risk associated with semaglutide compared to SGLT2 inhibitors, though absolute risk remains low.
8 min read
Brianna LaPaglia's Ozempic Warning: 3 Pressures Behind Viral Claim
Influencer Brianna 'Chickenfry' LaPaglia's TikTok blast—'You're gonna die. You're all gonna die.'—targets Ozempic use among those who 'do not need' it, sparking viral debate. Page Six coverage highlights three colliding pressures amid Baptist Health's side effect warnings. Her personal recovery from disordered eating adds weight to the caution.
5 min read
GLP-1 Risks for Seniors: Key Precautions for Older Adults
GLP-1 medications like Ozempic and Wegovy are transforming weight management, but older adults face heightened risks like muscle loss and fractures. This guide breaks down the science-backed concerns, monitoring strategies, and when to avoid them. Stay informed to make safer health choices.
4 min read
Counterfeit GLP-1 Pills: Risks and How to Stay Safe
Demand for GLP-1 weight loss medications is soaring, but the shift to easier-to-fake oral pills spells trouble. Counterfeit versions pose serious health risks, from incorrect dosing to contamination. This guide explains the threats and equips you with strategies to stay safe.
4 min read